Literature DB >> 21105273

Does clinical judgment of baseline severity and changes in psychopathology depend on the patient population? Results of a CGI and PANSS linking analysis in a naturalistic study.

Rebecca Schennach-Wolff1, Michael Obermeier, Florian Seemüller, Markus Jäger, Max Schmauss, Gerd Laux, Herbert Pfeiffer, Dieter Naber, Lutz G Schmidt, Wolfgang Gaebel, Joachim Klosterkötter, Isabella Heuser, Wolfgang Maier, Matthias R Lemke, Eckart Rüther, Stefan Klingberg, Markus Gastpar, Rolf R Engel, Hans-Jürgen Möller, Michael Riedel.   

Abstract

BACKGROUND: Linking of the Clinical Global Impression (CGI) Scale and the Positive and Negative Syndrome Scale (PANSS) was performed within a naturalistic sample. Furthermore, these linking results were compared with those derived from randomized controlled trials to examine if the baseline severity might influence the linking results.
METHODS: Biweekly PANSS and CGI ratings were performed from admission to discharge in 398 schizophrenia patients treated within a naturalistic study. Equipercentile linking was performed using the statistical program, R 2.8.1. To evaluate how the naturalistic study design would influence linkage results, a so-called study sample was computed with patients of the naturalistic study fulfilling common inclusion criteria of randomized controlled trials (n = 199). Patients not fulfilling these criteria (less ill sample) and those fulfilling the criteria (study sample) were compared using confidence intervals.
RESULTS: We found a considerable difference between the linking of the CGI severity score and the PANSS total score comparing the less ill sample and the study sample. Being considered "mildly ill" at admission in the less ill sample corresponded to a PANSS total score of 47 points and to a PANSS total score of 67 points in the study sample. Considering the linking of the CGI improvement score and PANSS changes, similar results were found for CGI improvement ratings ranging from "very much improved" to "minimally improved".
CONCLUSIONS: Despite considerable differences, a 50% PANSS reduction was found to correspond to a clinical rating of much improved, which seems to be a suitable definition for response in clinical drug trials.

Entities:  

Mesh:

Year:  2010        PMID: 21105273     DOI: 10.1097/jcp.0b013e3181faf39b

Source DB:  PubMed          Journal:  J Clin Psychopharmacol        ISSN: 0271-0749            Impact factor:   3.153


  8 in total

1.  Parallel but not equivalent: challenges and solutions for repeated assessment of cognition over time.

Authors:  Alden L Gross; Sharon K Inouye; George W Rebok; Jason Brandt; Paul K Crane; Jeanine M Parisi; Doug Tommet; Karen Bandeen-Roche; Michelle C Carlson; Richard N Jones
Journal:  J Clin Exp Neuropsychol       Date:  2012-04-30       Impact factor: 2.475

2.  Suicidal behavior in the older patient with schizophrenia.

Authors:  John Kasckow; Lori Montross; Laurie Prunty; Lauren Fox; Sidney Zisook
Journal:  Aging health       Date:  2011-06

Review 3.  The acute efficacy of antipsychotics in schizophrenia: a review of recent meta-analyses.

Authors:  Peter M Haddad; Christoph U Correll
Journal:  Ther Adv Psychopharmacol       Date:  2018-10-08

4.  Noninferiority of perphenazine vs. three second-generation antipsychotics in chronic schizophrenia.

Authors:  Robert Rosenheck; Haiqun Lin
Journal:  J Nerv Ment Dis       Date:  2014-01       Impact factor: 2.254

5.  Minimum clinically important difference in the Positive and Negative Syndrome Scale with data from the Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE).

Authors:  Eric D A Hermes; Daniel Sokoloff; T Scott Stroup; Robert A Rosenheck
Journal:  J Clin Psychiatry       Date:  2012-04       Impact factor: 4.384

6.  The Use of the Health of the Nation Outcome Scales for Assessing Functional Change in Treatment Outcome Monitoring of Patients with Chronic Schizophrenia.

Authors:  Stephan T Egger; Stefan Vetter; Godehard Weniger; Caroline Vandeleur; Erich Seifritz; Mario Müller
Journal:  Front Public Health       Date:  2016-10-13

7.  Response rates in patients with schizophrenia and positive symptoms receiving cognitive behavioural therapy: a systematic review and single-group meta-analysis.

Authors:  Irene Bighelli; Maximilian Huhn; Johannes Schneider-Thoma; Marc Krause; Cornelia Reitmeir; Sofia Wallis; Felicitas Schwermann; Gabi Pitschel-Walz; Corrado Barbui; Toshi A Furukawa; Stefan Leucht
Journal:  BMC Psychiatry       Date:  2018-12-04       Impact factor: 3.630

8.  Assessing the severity of functional impairment of psychiatric disorders: equipercentile linking the mini-ICF-APP and CGI.

Authors:  Stephan T Egger; Godehard Weniger; Mario Müller; Julio Bobes; Erich Seifritz; Stefan Vetter
Journal:  Health Qual Life Outcomes       Date:  2019-11-19       Impact factor: 3.186

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.